Mechanochemical activation of mixed raw clays: Influence of grinding parameters on process efficiency and physicochemical properties
ce/papers · 2026-10 · 9 (6) · 1496-1508
DOI: 10.1002/cepa.70974 ↗Kurz gefasst
Fachartikel in der Zeitschrift ce/papers, online erschienen am 27.10.2026. Verfasst von Roya Zeidler und 1 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Natural heterogeneous clays offer potential as alternative supplementary cementitious materials (SCMs) for CO 2 ‐reduced binder systems due to their pozzolanic properties and global availability. Mechanochemical activation (MCA) has emerged as an alternative method to enhance the reactivity particularly of mixed 2:1 clays. However, the influence of milling parameters and mineralogy is not yet fully understood. This study investigates the effect of varying milling parameters on two mixed raw clays low in kaolinite‐content – one illite‐ and one smectite‐based. Physical and structural changes induced by MCA are evaluated through particle size distribution, BET specific surface area, XRD, and heat flow calorimetry to assess the resulting reactivity enhancement.
Zitieren
APA
Zeidler, R., & Schmidt‐Döhl, F. (2026). Mechanochemical activation of mixed raw clays: Influence of grinding parameters on process efficiency and physicochemical properties. ce/papers, 9(6), 1496-1508. https://doi.org/10.1002/cepa.70974
Vancouver
Zeidler R, Schmidt‐Döhl F. Mechanochemical activation of mixed raw clays: Influence of grinding parameters on process efficiency and physicochemical properties. ce/papers. 2026;9(6):1496-1508. doi:10.1002/cepa.70974
BibTeX
@article{Zeidler2026,
author = {Zeidler, Roya and Schmidt‐Döhl, Frank},
title = {Mechanochemical activation of mixed raw clays: Influence of grinding parameters on process efficiency and physicochemical properties},
journal = {ce/papers},
year = {2026},
volume = {9},
number = {6},
pages = {1496--1508},
doi = {10.1002/cepa.70974}
}
EUVIMED